It is impossible to judge the survival time of lung cancer patients with leg weakness alone, and the survival time needs to be judged by a combination of various factors.
Lung cancer patients with leg weakness need to be alert to the occurrence of brain metastasis, bone metastasis or malignant state of the body, etc. The survival time of patients varies depending on the causes of leg weakness.
Brain metastasis: lung cancer patients are prone to brain metastasis. When intracranial tumor metastasis is formed, it can compress adjacent nerve tissues, leading to impaired motor and sensory functions and weakness of legs. When lung cancer patients develop spinal cord injury, similar manifestations can also appear. After brain metastasis occurs in lung cancer, the survival time is generally 3-5 years.
Bone metastasis: Lung cancer patients may also have bone metastasis, which is mostly osteolytic in nature, and the clinical manifestation is mainly bone and joint pain, or numbness of limbs and weakness of legs. With the progress of disease, pathological fracture may occur. After bone metastasis of lung cancer, the survival time is about 1-3 years.
Malignant state: lung cancer is a malignant tumor disease and also a consumptive disease, which causes large amount of consumption of human body, and the patient will have emaciation, poor nutritional status, electrolyte disorder and other manifestations, and will also have the clinical manifestation of leg weakness, at this time, the overall survival time of the patient needs to be decided according to the factors of the clinical typology, staging and treatment plan of lung cancer and other comprehensive factors.
Lung cancer patients with leg weakness need to go to specialized hospitals in time to clarify the cause of the disease, standardize diagnosis and treatment under the guidance of specialists, and have regular follow-ups. At the same time, patients are recommended to keep a good mindset and develop good living habits in order to prolong the survival time and improve the life treatment.